This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
ADSTILADRIN
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
ECLIPSE
ESCAPE
FORT
NRG-GU 0101
Masofaniten (EPI-7386)
METANOVA
RTIRE
SHORTER
Right Side
PCCTC
DORA
IRONMAN
PROMISE
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SESAUA 2024
Southern CA GU Cancer Research Forum 2024
AUA Urology Advocacy Summit 2024
ASCO GU 2024
2024 UCSF-UCLA PSMA Conference
SUO 2023
All Conferences
View All
PCF
UroToday Home
Conference Highlights
AUA 2017
AUA 2017
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testis & Penile Cancers
BPH
GU Reconstruction
Infections & Inflammation
Sexual Function
Stone Disease - Endourology & Technology
Urinary Incontinence
Press Releases
AUA 2017 Prostate Cancer
Viewing 81-100 of 132 articles
AUA 2017: Identifying the Optimal Candidate for Early Salvage Radiation Therapy after Radical Prostatectomy for Prostate Cancer: A Long-Term Multi-Institutional Analysis
: Impact of Metformin on Prostate Cancer Outcomes in the E3805 CHAARTED Trial
AUA 2017: The Effective Period of First Androgen-Deprivation Therapy Becomes a Prognostic Factor in Docetaxel Chemotherapy for Castration-Resistant Prostate Cancer Patients
AUA 2017: Comparison of the Length of Time from Initiation of Androgen Deprivation Therapy to Salvage Chemotherapy in African American Males and Caucasian Males with Castrate Resistant Prostate Cancer
AUA 2017: Does baseline serum testosterone influence androgen deprivation therapy outcomes for advanced prostate cancer patients?
AUA 2017: Measuring to Improve: Patient Reported Outcomes during the First Year after Prostatectomy in a Statewide Collaborative
AUA 2017: Association Between Early Continence and Erectile Function Recovery after Robot-Assisted Radical Prostatectomy: Development of a Novel Postoperative Risk Score To Optimize Patient Counseling and Follow-up
AUA 2017: DNA Repair Defects in Prostate Cancer
AUA 2017: Do Sicker People Have Worse Prostate Cancer-Specific Outcomes After Radical Prostatectomy? Results from SEARCH
AUA 2017: Evaluation of Prebiopsy Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer in Men Aged 75 Years and Older with Elevated PSA
AUA 2017: Combining 4KScore and Magnetic Resonance Imaging (MRI) for Prostate Biopsy Decision Making
AUA 2017: Does baseline serum testosterone influence androgen deprivation therapy outcomes for advanced prostate cancer patients?
AUA 2017: Determinants of Default From Follow-Up Care in a Prostate Cancer Screening Program
AUA 2017: Reflex Testing with Serum, Urine, and Tissue Biomarkers – Which, When and How Valuable?
AUA 2017: Genetic Testing in Inherited Prostate Cancer Risk: Consensus Statement
AUA 2017: Best Prostate Cancer Papers from Past Years
AUA 2017: Personalized Decision Support for Localized Prostate Cancer: Results of a Multi-site Randomized Trial
AUA 2017: Long-Term Health Related Quality of Life in Prostate Cancer Patients Requiring Radiotherapy After Radical Prostatectomy
AUA 2017: USPSTF Fallout – Is Disease Burden at Diagnosis of Metastatic Disease Rising?
AUA 2017: Comparative Assessment of Efficacies Between Two Alternative Therapeutic Sequences with Novel Androgen Receptor-axis-targeted Agents in Patients With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer
1
2
3
4
5
6
7
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free